Emerson (EMR) PT Raised to $62 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $166.41 +0.27%
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 12
Rating Summary:
27 Buy, 19 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 12
Join SI Premium – FREE
Barclays analyst Julian Mitchell raised the price target on Emerson (NYSE: EMR) to $62.00 (from $54.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Emerson (EMR) PT Lowered to $140 at Morgan Stanley
- Essential Properties Realty Trust (EPRT) PT Lowered to $31 at Cantor Fitzgerald
- MYR Group (MYRG) PT Lowered to $386 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
